NCI has funded five research teams to participate in its Pediatric Preclinical Testing Consortium.
President Barack Obama nominated Robert Califf to the post of Commissioner of Food and Drugs.
MD ANDERSON CANCER CENTER and Esperance Pharmaceuticals Inc. entered into a strategic alliance to accelerate the clinical development of its lead anti-cancer candidate, EP-100, for the treatment of ovarian cancer, and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.
NCI is planning to increase funding for the Cancer Center Core Grants, Acting Director Douglas Lowy said to the National Cancer Advisory Board at a meeting Sept. 16.
ROBIN DAVISSON was named president and CEO-elect of the Melanoma Research Alliance effective Oct. 1.
The NCI Bypass Budget for 2017 asks for a 7-percent increase over fiscal 2016, followed by a series of annual 7-percent increases that would continue through 2026, when the institute's budget would double.
BROAD INSTITUTE and MD ANDERSON CANCER CENTER were designated the Genome Characterization Centers in a five-year project supported by the NCI to characterize the genomic changes found in tumors.
NIH, NCI and FDA should receive budget increases of at least 7 percent a year, the 2015 Cancer Progress Report by the American Association for Cancer Research recommends.
Gianni Bonadonna, 81, a pioneering cancer researcher whose work focused on Hodgkin's lymphoma and breast cancer, died Sept. 7.
LOIS TRAVIS was named the Lawrence H. Einhorn Professor of Cancer Research at the Indiana University School of Medicine and director of the Cancer Survivorship Research Program at the IU Melvin and Bren Simon Cancer Center.